# QED Prediction Analysis for m05

## Search Strategy
I searched for molecules containing the scaffold substring `COc1ccc(cc1)C(=O)N` which represents the core structure of the target molecule m05 without its long alkyl chain. This search returned 6 molecules total.

## Congeners Found
All molecules share the same scaffold `COc1ccc(cc1)C(=O)N` with varying N-alkyl chain lengths:

1. **m15**: `COc1ccc(cc1)C(=O)NCC` - C2 alkyl chain (ethyl)
2. **m24**: `COc1ccc(cc1)C(=O)NCCC` - C3 alkyl chain (propyl)
3. **m28**: `COc1ccc(cc1)C(=O)NCCCC` - C4 alkyl chain (butyl)
4. **m17**: `COc1ccc(cc1)C(=O)NCCCCC` - C5 alkyl chain (pentyl)
5. **m22**: `COc1ccc(cc1)C(=O)NCCCCCC` - C6 alkyl chain (hexyl)
6. **m05**: `COc1ccc(cc1)C(=O)NCCCCCCCCCCC` - C11 alkyl chain (undecyl) - TARGET

## Measured QED Values
I measured QED for all 5 measurable congeners:

| Molecule | Chain Length (C atoms) | QED |
|----------|------------------------|-----|
| m15      | 2                     | 0.7621 |
| m24      | 3                     | 0.7919 |
| m28      | 4                     | 0.7518 |
| m17      | 5                     | 0.7498 |
| m22      | 6                     | 0.7377 |

## Trend Analysis
The QED trend shows:
1. **Peak at C3**: Maximum QED of 0.7919 occurs with the propyl chain (m24)
2. **Decline after C3**: QED decreases as chain length increases beyond C3
3. **Pattern**: C2→C3: +0.0298 increase, C3→C4: -0.0401 decrease, C4→C5: -0.0020 decrease, C5→C6: -0.0121 decrease

The decline after C3 suggests that longer alkyl chains negatively impact drug-likeness, likely due to:
- Increased molecular weight (mw increases ~14 Da per carbon)
- Increased lipophilicity (alogp increases ~0.39 per carbon)
- Increased rotatable bonds (rotb increases by 1 per carbon)

## Extrapolation to C11
Target m05 has C11 chain, which is 5 carbons longer than the longest measured congener (m22, C6).

Key observations for extrapolation:
1. The QED decrease from C5 to C6 (-0.0121) is larger than from C4 to C5 (-0.0020)
2. Molecular properties continue deteriorating linearly with chain length
3. m05 has significantly higher mw (305.46 vs 235.33 for C6) and alogp (4.956 vs 3.005 for C6)

Given that:
- The largest single-step decrease observed was C3→C4 (-0.0401)
- The C5→C6 decrease was -0.0121
- Longer chains typically show diminishing negative impact but m05's properties are extreme

I considered several extrapolation approaches:
1. **Linear trend from C3-C6**: Average decrease per carbon = (0.7919 - 0.7377)/3 = -0.01807
   Extrapolation: 0.7377 - (5 * 0.01807) = 0.7377 - 0.09035 = 0.64735

2. **Conservative estimate**: Using the C5→C6 rate (-0.0121 per carbon) for 5 carbons:
   0.7377 - (5 * 0.0121) = 0.7377 - 0.0605 = 0.6772

3. **Weighted approach**: The negative impact likely accelerates with very long chains due to poor drug-like properties. m05's alogp (4.956) exceeds the optimal range (<5 for oral drugs), and its 12 rotatable bonds exceed the typical limit (<10).

## Final Prediction
Given that m05's properties (mw=305.46, alogp=4.956, rotb=12) are well outside the optimal ranges for drug-like molecules, and considering:
- The clear downward trend beyond C3
- The accelerating negative impact suggested by descriptor deterioration
- Standard QED calculation weighs molecular weight, lipophilicity, and rotatable bonds negatively

I predict m05's QED will be **0.620**. This accounts for the significant property deterioration while recognizing that the decrease rate might not be perfectly linear.

## Budget Usage
- Search queries: 2 pages used (2 budget units)
- Measurements: 5 molecules measured (5 budget units)
- Total used: 7/12 budget units